44 results on '"Raymond, Stéphanie"'
Search Results
2. SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing
3. Whole‐genome single molecule real‐time sequencing of SARS‐CoV‐2 Omicron
4. HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment
5. Whole‐genome sequencing of SARS‐CoV‐2: Comparison of target capture and amplicon single molecule real‐time sequencing protocols
6. Influence of Nasopharyngeal Viral Load on the Spread of the Omicron BA.2 Variant
7. Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
8. Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load
9. Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study
10. Maraviroc exposure is influenced by exogenous thyrotoxicosis
11. L’expertise forensique judiciaire numérique ou l’art d’identifier le cyberattaquant par une cyberenquête
12. Sexual transmission of an extensively drug-resistant HIV-1 strain
13. Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens
14. Performance of the Xpert HBV Viral Load assay versus the Aptima Quant assay for quantifying hepatitis B virus DNA
15. Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance
16. Long-term evolution of transmitted CXCR4-using HIV-1 under effective antiretroviral therapy
17. THETA: a new genotypic approach for predicting HIV-1 CRF02-AG coreceptor usage
18. HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy
19. CCR5 structural plasticity shapes HIV-1 phenotypic properties
20. Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing
21. Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene
22. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform
23. Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen
24. Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy
25. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma
26. Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use
27. Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus
28. Brief Report: HIV-1 Tropism During Primary Infections in France: 1996–2014
29. No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV-infected patients on suppressive maraviroc therapy
30. Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism
31. Genotypic Prediction of HIV-1 CRF01-AE Tropism
32. Phenotyping methods for determining HIV tropism and applications in clinical settings
33. Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing
34. Genotypic prediction of HIV-1 subtype D tropism
35. Low Frequency of CXCR4-Using Viruses in Patients at the Time of Primary Non-Subtype-B HIV-1 Infection
36. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression
37. Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study
38. Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc
39. Prediction of HIV Type 1 Subtype C Tropism by Genotypic Algorithms Built From Subtype B Viruses
40. Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage
41. HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
42. Determining Seminal Plasma Human Immunodeficiency Virus Type 1 Load in the Context of Efficient Highly Active Antiretroviral Therapy
43. Genotypic Prediction of Human Immunodeficiency Virus Type 1 CRF02-AG Tropism
44. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.